39 studies found for:    hemochromatosis
Show Display Options
RSS Create an RSS feed from your search for:
hemochromatosis
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Erythrocyte Apheresis Versus Phlebotomy in Hemochromatosis
Condition: Hemochromatosis
Interventions: Procedure: Arm 1: Erythrocyte apheresis;   Procedure: Arm 2: Whole blood phlebotomy
2 Recruiting Treatment of Hemochromatosis
Condition: Hemochromatosis
Intervention:
3 Active, not recruiting Cardiac Function in Patients With Hereditary Hemochromatosis
Condition: Hemochromatosis
Intervention:
4 Recruiting Treatment of Iron Overload With Deferasirox (Exjade) in Hereditary Hemochromatosis and Myelodysplastic Syndrome
Conditions: Hemochromatosis;   Myelodysplastic Syndromes
Interventions: Drug: Deferasirox;   Other: Venesection
5 Recruiting Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis
Condition: Hemochromatosis Type 1
Intervention: Procedure: First evaluation phase : no intervention / Second evaluation phase: bloodletting of 7 ml/kg (with a maximum of 500ml)
6 Active, not recruiting Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study
Condition: Genetic Hemochromatosis
Intervention:
7 Not yet recruiting Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study
Condition: Refractory Hemochromatosis Rheumatism
Intervention: Drug: Anakinra
8 Active, not recruiting Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
Condition: Hereditary Hemochromatosis
Intervention: Other: Phlebotomy and  erythrocytapheresis
9 Completed
Has Results
Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
Conditions: Iron Overload;   Hereditary Hemochromatosis
Intervention: Drug: Deferasirox (ICL670)
10 Completed HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis
Condition: Hereditary Hemochromatosis C282Y Homozygous
Intervention:
11 Not yet recruiting Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis
Conditions: Myocardial Iron Overload;   HFE-Associated Hereditary Hemochromatosis
Interventions: Device: 3Tesla cardiac MRI;   Device: Electrocardiogram (EKG);   Biological: Iron and cardiac markers;   Biological: Pregnancy test;   Device: Echocardiography at rest;   Biological: Urinary pregnancy test;   Device: 3Tesla abdominal MRI
12 Completed Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy
Condition: Hemochromatosis
Interventions: Procedure: Phlebotomy;   Procedure: Erythrocytapheresis
13 Completed Deferoxamine for the Treatment of Hemochromatosis
Conditions: Diabetes Mellitus;   Heart Disease;   Hemochromatosis;   Thalassemia
Intervention:
14 Unknown  Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis
Condition: Hemochromatosis
Intervention: Drug: Pantoprazole
15 Completed Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
Condition: Hereditary Hemochromatosis
Intervention: Procedure: Eritrocytoapheresis
16 Not yet recruiting Implications for Quality of Life and Quality of Care in Patients With Hereditary Haemochromatosis
Condition: Hereditary Haemochromatosis
Intervention: Other: Interviews, questionaires, RAND-modified delphi method round
17 Completed Hemochromatosis--Genetic Prevalence and Penetrance
Conditions: Blood Disease;   Hemochromatosis
Intervention:
18 Completed Hemochromatosis and Iron Overload Screening Study (HEIRS)
Conditions: Blood Disease;   Hemochromatosis;   Iron Overload
Intervention:
19 Completed Statistical Basis for Hemochromatosis Screening
Conditions: Blood Disease;   Hemochromatosis
Intervention:
20 Completed Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
Conditions: Anemia (Iron-Loading);   Beta-Thalassemia;   Hematologic Diseases;   Hemoglobinopathies;   Thalassemia;   Iron Overload;   Hemochromatosis
Intervention: Drug: deferoxamine

   Previous Page Studies Shown (1-20) Next Page (21-39) Show next page of results    Last Page
Indicates status has not been verified in more than two years